Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress
Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress
复制标题
Oroxylin A 通过内质网应激诱导活化肝星状细胞凋亡
DOI:
10.1007/s10495-019-01568-2
复制
发表时间:
2019-12-01
期刊:
影响因子:
7.2
通讯作者:
Zheng, Shizhong
中科院分区:
文献类型:
--
作者:
Bian, Mianli;He, Jianlin;Zheng, Shizhong
Hepatic stellate cell (HSC) activation plays an indispensable role in hepatic fibrosis. Inducing apoptosis of activated HSCs can attenuate or reverse fibrogenesis. In this study, we initially found that oroxylin A (OA) protected CCl4-induced liver injury accompanied by endoplasmic reticulum stress (ERS) activation of HSCs in mice. In vitro, OA treatment markedly reduced fibrogenesis by modulating extracellular matrix synthesis and degradation. OA inhibited cell proliferation and induced cell cycle arrest of HSCs at S phase. Further, OA was observed to induce HSC apoptosis, as indicated by caspase activation. Using the eIF2 alpha dephosphorylation inhibitor salubrinal, we found that ERS pathway activation was required for OA to induce HSC apoptosis. ERS-related proteins were significantly upregulated by OA treatment, and salubrinal abrogated the effects of OA on HSCs. Thus, we inferred that OA attenuated HSC activation by promoting ERS. In vivo, inhibition of ERS by salubrinal partly abrogated the hepatoprotective effect of OA in CCl4-treated mice. In conclusion, our findings suggest a role for ERS in the mechanism underlying amelioration of hepatic fibrosis by OA.